Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Błażej Rychlik

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Pharmacological and Toxicological Methods|November 14, 2016
Drug-selected cell line panels for evaluation of the pharmacokinetic consequences of multidrug resistance proteinsAndrzej Błauż, Błażej Rychlik
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Oncostatin M reverses ABCG2-mediated mitoxantrone resistanceAndrzej Błauż, Marcin Wachulec, Błażej Rychlik
Thescientificworldjournal|February 28, 2014
The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cellsAneta Rogalska, Marzena Szwed, Błażej Rychlik
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2026
Oncostatin M-induced ABCC2 suppression sensitizes hepatocellular carcinoma cells to chemotherapeuticsMaciej Przywarty, Błażej Rychlik, Anna Wieczorek-Błauż, et al.
Advanced Drug Delivery Reviews|October 15, 2013
Multidrug resistance: Physiological principles and nanomedical solutionsSijumon Kunjachan, Błażej Rychlik, Gert Storm, et al.
Dalton Transactions (Cambridge, England : 2003)|July 29, 2017
Synthesis and evaluation of biological properties of ferrocenyl-podophyllotoxin conjugatesAnna Wieczorek, Andrzej Błauż, Anna Makal, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR CellsAnna Wieczorek, Andrzej Błauż, Janusz Zakrzewski, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 3, 2011
Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockadeWiktor Kuliczkowski, Błażej Rychlik, Krzysztof Chiżyński, et al.
Dalton Transactions (Cambridge, England : 2003)|September 18, 2024
Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitorsKarolina Kowalczyk, Andrzej Błauż, Krzysztof Krawczyk, et al.
ACS Omega|April 29, 2024
Development of Half-Sandwich Ru, Os, Rh, and Ir Complexes Bearing the Pyridine-2-ylmethanimine Bidentate Ligand Derived from 7-Chloroquinazolin-4(3H)-one with Enhanced Antiproliferative ActivityMichał Łomzik, Andrzej Błauż, Daniel Tchoń, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Pharmacological and Toxicological Methods|November 14, 2016
Drug-selected cell line panels for evaluation of the pharmacokinetic consequences of multidrug resistance proteinsAndrzej Błauż, Błażej Rychlik
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Oncostatin M reverses ABCG2-mediated mitoxantrone resistanceAndrzej Błauż, Marcin Wachulec, Błażej Rychlik
Thescientificworldjournal|February 28, 2014
The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cellsAneta Rogalska, Marzena Szwed, Błażej Rychlik
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2026
Oncostatin M-induced ABCC2 suppression sensitizes hepatocellular carcinoma cells to chemotherapeuticsMaciej Przywarty, Błażej Rychlik, Anna Wieczorek-Błauż, et al.
Advanced Drug Delivery Reviews|October 15, 2013
Multidrug resistance: Physiological principles and nanomedical solutionsSijumon Kunjachan, Błażej Rychlik, Gert Storm, et al.
Dalton Transactions (Cambridge, England : 2003)|July 29, 2017
Synthesis and evaluation of biological properties of ferrocenyl-podophyllotoxin conjugatesAnna Wieczorek, Andrzej Błauż, Anna Makal, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR CellsAnna Wieczorek, Andrzej Błauż, Janusz Zakrzewski, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 3, 2011
Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockadeWiktor Kuliczkowski, Błażej Rychlik, Krzysztof Chiżyński, et al.
Dalton Transactions (Cambridge, England : 2003)|September 18, 2024
Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitorsKarolina Kowalczyk, Andrzej Błauż, Krzysztof Krawczyk, et al.
ACS Omega|April 29, 2024
Development of Half-Sandwich Ru, Os, Rh, and Ir Complexes Bearing the Pyridine-2-ylmethanimine Bidentate Ligand Derived from 7-Chloroquinazolin-4(3H)-one with Enhanced Antiproliferative ActivityMichał Łomzik, Andrzej Błauż, Daniel Tchoń, et al.
Pageof 3